Literature DB >> 2858744

Evidence that respiratory tract is major reservoir for Epstein-Barr virus.

M L Lung, W K Lam, S Y So, W P Lam, K H Chan, M H Ng.   

Abstract

Exfoliated cells harvested from bronchial washings of 53 patients with suspected bronchogenic carcinoma were tested by means of DNA dot hybridisation using the cloned large internal repeat (IR) sequence of Epstein-Barr virus (EBV) genome as a probe. 25 of these patients gave positive results. Since the patients had diseases that were not related to the virus, this finding suggests that the lower respiratory tract is a major reservoir for EBV. Attempts at cellular localisation of the virus revealed only an occasional cell which harboured the viral genome or expressed viral capsid antigens. These cells could not account for the quantity of the viral DNA detected in bronchial washings. Moreover, patients had similar profiles of serum EBV antibodies whether they were positive or negative for EBV DNA by dot hybridisation. These findings are compatible with a state of viral latency in which cells harbour a low copy number of the viral genome. Viral expression rarely occurs in these cells, which seem to elicit a minimum host immune response. If it is assumed that each latently infected cell harbours a maximum of approximately 30 EBV genomes (which is the lower limit of detection by the in-situ hybridisation method used in this study), the findings suggest that a considerable proportion of the exfoliative cells from the lower respiratory tract, of the order of 0.1-16%, harbour latent EBV.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858744     DOI: 10.1016/s0140-6736(85)91671-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection.

Authors:  K H Chan; M H Ng; W H Seto; J S Peiris
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

3.  Epstein-Barr virus-associated pneumonia and bronchiolitis obliterans syndrome in a lung transplant recipient.

Authors:  Andi Krumbholz; Tim Sandhaus; Angela Göhlert; Albert Heim; Roland Zell; Renate Egerer; Martin Breuer; Eberhard Straube; Peter Wutzler; Andreas Sauerbrei
Journal:  Med Microbiol Immunol       Date:  2010-07-20       Impact factor: 3.402

4.  Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia.

Authors:  P M Kaan; R G Hegele; S Hayashi; J C Hogg
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

5.  Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells.

Authors:  S Imai; J Nishikawa; K Takada
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Infectious mononucleosis: a cause of bilateral hilar lymphadenopathy.

Authors:  J S Friedland; G Santis; M J Smith
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

7.  Epstein-Barr virus and cryptogenic fibrosing alveolitis.

Authors:  J C Hogg
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

8.  Does an Epstein-Barr viral infection influence the pathogenesis of a primary pulmonary B-cell lymphoma?

Authors:  A Tamura; M Kitagawa; H Komatsu; R Takano; J Wakimoto; J Homma; A Nagase; E Nemoto; N Yanai
Journal:  Lung       Date:  1995       Impact factor: 2.584

9.  Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis.

Authors:  K Tsukamoto; H Hayakawa; A Sato; K Chida; H Nakamura; K Miura
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

10.  Detection of herpesvirus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract?

Authors:  I Friedrichs; T Bingold; O T Keppler; B Pullmann; C Reinheimer; A Berger
Journal:  Med Microbiol Immunol       Date:  2013-07-31       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.